New book by Larry Connors Click here Improve your trading - See how
To achieve rapid adoption of the CRH Technology by a broad segment of the medical community, the Company developed a strategic initiative to sell the Company's patented proprietary hemorrhoid banding technology, treatment protocols, marketing and operational experience directly to physicians who see patients that may be in need of hemorrhoid treatment. By adopting the use of the CRH Technology, the physician increases practice revenues, expands the continuum of care and provides a fast, painless and permanent solution to patients. The Company's initial target for this Program is the approximately 11,000 Gastroenterologists in the U.S. who perform approximately 14 million colonoscopies each year. The Company estimates that symptomatic hemorrhoids are diagnosed in 15 - 20% of all colonoscopy patients, most of which go untreated.
Commenting on this achievement, Edward Wright CEO of CRH Medical Corporation stated, "This training milestone demonstrates the substantial demand for our technology and treatment protocol by Gastroenterologists. The Gastroenterologists and practices that have been trained are experiencing significant clinical and financial results. Although the Program is in its infancy, we are encouraged by the results and look forward to further expanding this strategy."
Dr. Steve Morris, Managing Partner of Atlanta Gastroenterology Associates stated "23 of 47 Gastroenterologists in our practice have been trained with the CRH Technology and treatment protocols. I believe the CRH Technology provides Atlanta Gastroenterology with the ability to significantly improve patient outcomes and enhance our profitability."
Dr. Harry Sarles, Finance Committee Chairman, Digestive Health Associates of Texas states, "The CRH Technology and treatment protocols enable Gastroenterologists to provide an effective hemorrhoid treatment to the significant number of patients who are either diagnosed with hemorrhoids during their colonoscopy or are referred to us complaining of hemorrhoidal pain and bleeding."
About CRH Medical Corporation:
CRH Medical Corporation is utilizing the first single use, patented, disposable, hemorrhoid banding system through its Center for Colorectal Health facilities. According to the National Institute of Health approximately 50% of the U.S. population will develop hemorrhoids by age 50. CRH Medical is opening its Center for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids, anal fissures, and colon cancer screening and plans to significantly increase the number of Centers for Colorectal Health across the U.S. to address this underserved market. The Company's goal is to become the preeminent resource on colorectal health for consumers and medical professionals in North America.
About Atlanta Gastroenterology Associates:
Established more than 20 years ago, Atlanta Gastroenterology is the largest gastroenterology practice in the southeast United States dedicated to the evaluation and treatment of both digestive and liver diseases. Today, AGA has more than 45 physicians in 15 locations conveniently located throughout the metropolitan Atlanta area and in north Georgia.
About Digestive Health Associates of Texas:
One of the largest gastroenterology physician groups in the United States. With more than 30 locations covering a 100-mile radius, providing health care services for the Dallas/Fort Worth Metroplex area.
The information in this news release contains so-called "forward-looking" statements. These include statements regarding CRH Medical expectations, beliefs, intentions or strategies for the future, which may be indicated by words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we believe", "CRH Medical believes", "management believes" and similar language. All forward-looking statements are based on CRH Medical current expectations and are subject to risks and uncertainties and to assumptions made.
<< The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release. >>
SOURCE: CRH Medical Corporation
Dean Linden, Corporate Communications, CRH Medical Corporation at (604) 633-1440 or ir@crhmedcorp.com. Additional information may also be found by visiting the Company's website at www.crhmedcorp.com or the SEDAR website at www.sedar.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
